GSK/Ranbaxy Deal Gives Indian Firm Greater Development Charge
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline and Ranbaxy Laboratories broadened a 2003 agreement to give the Indian company new responsibilities for developing drug candidates, the companies announced Feb. 6